The present invention relates to compounds of 2-thia-dibenzoazulene class,
to their pharmacologically acceptable salts and solvates, to processes
and intermediates for the preparation thereof as well as to their
antiinflammatory effects, especially to the inhibition of tumour necrosis
factor-.alpha.(TNF-.alpha.) production and the inhibition of
interleukin-1 (IL-1) production as well as to their analgetic action.